Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2011/09/002023
CTRI/2011/09/002023CompletedPhase 4

Treatment of Early Neuropathy in Leprosy (TENLEP).Trial 2-randomized, double- blind,placebo-controlled trial to determine whether steroid treatment of 32 weeks duration is more effective than treatment with 20 week duration in restoring nerve function in patients with clinical neuropathy and or motor NFI of recent onset (less than 6 months) - TENLEP

Royal Tropical Institute KIT0 sites655 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
655
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •All newly detected leprosy patients

Exclusion Criteria

  • •1) Any leprosy patient with single lesion on the trunk as the only sign of leprosy
  • •2) Any patient over 60 or under 15 on the basis of legal document
  • •3) Women with known pregnancy at the time of diagnosis
  • •4) People with known other conditions that may affect the peripheral nervous system (e.g. diabetes, alcohol abuse, HIV/Aids, carpel tunnel syndrome , nerve injuries) through specific history talking DM test, PICT for HIV, liver function tests.
  • •5) Any patient refusing informed consent.
  • •6) Any patient for whom full dose of steroid would be indicated for reasons other than recent nerve function impairment.

Investigators

Sponsor
Royal Tropical Institute KIT

Similar Trials

Recruiting
Phase 4
Treatment of Early Neuropathy in Leprosy
CTRI/2011/09/002022Royal Tropical Institute KIT790
Not yet recruiting
Not Applicable
Treatment of Early Neuropathy in Leprosy.neuropathy, neuritis, leprosy
NL-OMON22418Royal Tropical InstituteAmsterdam1,250
Unknown
Phase 3
Treatment of Neuropathic Pain in LeprosyPain, NeuropathicLeprosy NeuropathyAmitriptylineLeprosy
NCT03324035University of Sao Paulo102
Not yet recruiting
Not Applicable
Interventtion study for peripheral neuropathy derived from chemotherapy. Effectiveness of green bamboo stepping for sole.cancer
JPRN-UMIN000035424shinshu univarsity school of medicine10
Completed
Not Applicable
Reduction of disability in leprosy through enhanced self-carePrevention of disability in leprosy (Hansen's disease)Infections and Infestations
ISRCTN17277275niversity of Birmingham250
Treatment of Early Neuropathy in Leprosy | Clinical Trial